RxDoctor Payments Data

John Price

Physician Assistant · Atlanta, GANPI 1447852199

Payments from drug & device makers

$3,365in general payments, 2019–2025

Across 123 payments — averaging $27.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$773
  • Johnson & Johnson$412
  • Boston Scientific$310
  • Blue Earth Diagnostics$256
  • Myriad Genetic Laboratories, Inc.$243
  • Endo Pharmaceuticals Inc.$206
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,16394%
  • Education$2026%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,365 in reported general payments places this provider in the 85th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron119$75,834
GemtesaVibegron12$8,812
Trospium Chloride ErTrospium Chloride21$6,203
Tamsulosin Hcl222$3,246
Fesoterodine Fumarate ErFesoterodine Fumarate32$2,967
Desmopressin Acetate23$2,680
Bethanechol Chloride46$1,984
Estradiol16$1,617
Solifenacin Succinate60$1,597
Trospium Chloride14$739
Bicalutamide16$717
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip25$587
Alfuzosin Hcl ErAlfuzosin Hcl15$349
Duloxetine Hcl14$290
Finasteride12$263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$146$75,834119 claims
Sumitomo Pharma America, Inc.Gemtesa$201$8,81212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →